Impact of dosage frequency on patient compliance

Diabetes Care

Volumn 20, Issue 10, 1997, Pages 1512-1517

  Paes, Arsenio H P ^a   Barker, Albert ^a   Soe Agnie, Carmen J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE;

EID: 0030823120     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.10.1512     Document Type: Article

References (69)

1. Stunkard AJ: Adherence to medical treatment: over-view and lessons from behavioral weight control. J Psychosom Res 25:187-197,1981
2. Levy RA: Failure to refill prescriptions. In Patient Compliance in Medical Practice and Clinical Trials. Cramer JA, Spilker B, Eds. New York, Raven Press, 1991, p. 11-18
3. Bond WS, Hussar DA: Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 48:1978-1988, 1991
4. Urquhart J: Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J 68 (Suppl. 3):S49-S59, 1992
5. Blom ATG, Paes AHP: De therapie-trouw kan worden verbeterd [Patient compliance can be improved]. Geneesmiddelenbulletin 26:40-43, 1992
6. Paes A, Cornips J: Gebruik volgens voorschrift [Use as indicated]. Intermediair 16:1-11, 1980
7. Wright EC: Non-compliance: or how many aunts has Matilda? Lancet 342:909-913, 1993
8. Epstein LH: The direct effects of compliance on health outcome. Health Psychol 3:385-393, 1984
9. Mikael RL, Sharpe T: Patient compliance. In Pharmacy Practice. Wertheimer AI, Smith MC, Eds. Baltimore, MD, University Park Press, 1974, p. 179-194
10. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL: How often is medication taken as prescribed? A novel assessment technique. JAMA 261:3273-3277, 1989
11. Bockowski JA, Zeichner A: Medication compliance and the elderly. Clin Gerontol 4:3-15, 1985
12. Weingarten MA, Cannon BS: Age as a major factor affecting adherence to medication for hypertension in a general practice population. Fam Practice 5:294-296, 1988
13. Evans L, Spelman M: The problem of non-compliance with drug therapy. Drugs 25:63-76, 1983
14. Owens NJ, Larrat EP, Fretwell MD: Improving compliance in the older patient: the role of comprehensive functional assessment. In Patient Compliance in Medical Practice and Clinical Trials. Cramer JA, Spilker B, Eds. New York, Raven Press, 1991, p. 107-119
15. Stuart B, Coulson NE: Dynamic aspects of prescription drug use in an elderly population. Health Res 28:237-264, 1993
16. Howie VM, Ploussard JH: Compliance dose-response relationships in streptococcal pharyngitis. Am J Dis Child 123:18-25, 1972
17. Luescher TF, Vetter H, Siegenthaler W, Vetter W: Compliance in hypertension: facts and concepts. J Hypertension 3 (Suppl. 1):3-9, 1985
18. Hammel RJ: Increased compliance means better health for patients, higher profits for you. Am Druggist 184:98, 1981
19. Gatley MS: To be taken as directed. J R Coll Gen Pract 16:39-44, 1968
20. Ayd FJ: Once-a-day neuroleptic and tricyclic antidepressant therapy. Int Drug Ther Newslet 7:33-40, 1972
21. Ayd FJ: Rational pharmacotherapy: once-a-day dosage. Dis Nerv Syst 34:371-378, 1973
22. Wandless I, Mucklow JC, Smith A, Prudham D: Compliance with prescribed medicines: a study of elderly patients in the community. J R Coll Gen Pract 29:391-396, 1979
23. Fujii J, Akira S: Compliance and compliance-improving strategies in hypertension: the Japanese experience. J Hypertens 3 (Suppl.):19-22, 1985
24. Cockburn J, Gibberd RW, Reid AL, Sanson-Fisher RW: Determinants of non-compliance with short term antibiotic regimens. Br Med J 295:814-818, 1987
25. Pullar T, Birtwell AJ, Wiles PG, Hay A, Seely MP: Use of pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 44:540-545, 1988
26. Sclar DA: Improving medication compliance: a review of selected issues. Clin Ther 13:436-440, 1991
27. Nicholas WC, Fisher RG, Stevenson RA, Bass JD: Single daily dose of methimazole compared to every 8 h propylthiouracil in the treatment of hyperthyroidism. South Med J 88:973-976, 1995
28. Waeber B, Erne P, Saxenhofer H, Heynen G: Use of drugs with more than a 24-h duration of action. J Hypertens 12:S67-S71, 1994
29. Detry JM, Block P, De Backer G, Degaute JP, Six R: Patient compliance and therapeutic coverage: amlodipine versus nifedipine (slow-release) in the treatment of angina pectoris: Belgian Collaborative Group. J Int Med Res 22:278-286, 1994
30. Sclar DA, Tartaglione TA, Fine MJ: Overview of issues related to medical compliance with implications for the outpatient management of infectious diseases. Infect Agents Dis 3:266-273, 1994
31. Widmer RB, Cadoret RJ, Troughton E: Compliance characteristics of 291 hypertensive patients from a rural midwest area. J Fam Pract 17:619-625, 1983
32. Leirer VO, Morrow DG, Pariante GM, Sheikh JI: Elders' nonadherence: its assessment, and computer assisted instruction for medication recall training. J Am Geriatr Soc 36:877-884, 1988
33. Kruse W, Rampmaier J, Ullrich G, Weber E: Patterns of drug compliance with medication to be taken once and twice daily assessed by continuous electronic monitoring in primary care. Int J Clin Pharmacol Ther 32:452-457, 1994
34. Kruse W, Eggert-Kruse W, Rampmaier J, Runnebaum B, Weber E: Dosage frequency and drug-compliance behavior: a comparative study on compliance with a medication to be taken twice or four times daily Eur J Clin Pharmacol 41:589-592, 1991
35. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Pzybeck TR: The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 150:1881-1884, 1990
36. Taggart AJ, Johnson GD, McDevitt DG: Does the frequency of daily dosage influence compliance with digoxin therapy? Br J Clin Pharmacol 1:31-34, 1981
37. Greenberg RN: Overview of patient compliance with medication dosing: a literature review. Clin Ther 6:592-599, 1984
38. Farmer KC, Jacobs EW, Phillips CR: Long-term patient compliance with prescribed regimens of calcium channel blockers. Clin Ther 16:316-326, 1994
39. Kruse W, Koch GP, Nikolaus T, Oster P, Schlierf G, Weber E: Measurement of drug compliance by continuous electronic monitoring: a pilot study in elderly patients discharged from hospital. J Am Geriatr Soc 40:1151-1155, 1992
40. Meredith PA: Patient compliance (Letter). BMJ 305:1434, 1992
41. Kruse W, Rampmaier J, Ullrich G, Weber E: Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care. Int J Clin Pharmacol Ther 32:452-457, 1994
42. Brun J: Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study. J Int Med Res 22:266-272, 1994
43. Kruse W, Weber E: Dynamics of drug regimen compliance: its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 38:561-565, 1990
44. Rudd P, Ramesh J, Bryant-Kosling C, Guerrero D: Gaps in cardiovascular medication taking: the tip of the iceberg. J Gen Intern Med 8:659-666, 1993
45. Mengden T, Binswanger B, Spühler T, Weisser B, Vetter W: The use of self-measured blood pressure determinants in assessing dynamics of drug compliance in a study with amlodipine once a day morning versus evening. J Hypertens 11:1403-1411, 1993
46. Averbuch M, Weintraub M, Pollock DJ: Compliance assessment in clinical trials: the MEMS device. J Clin Res Pharmacoepidemiol 4:199-204, 1990
47. Urquhart J: When outpatient drug treatment fails: non-complier or non-responder: identifying non-compliers as a cost-containment tool. Clin Res Reg Affairs 11:19-38, 1994
48. Cramer JA: Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 49:321-327, 1995
49. Kruse W, Nikolaus T, Rampmaier J, Weber E, Schlierf G: Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring. Eur J Clin Pharmacol 45:211-215, 1993
50. Mallion JM, Meilhac B, Tremel F, Calvez R, Bertholom N: Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment. J Cardiovasc Pharmacol 19 (Suppl. 2):S41-S48, 1992
51. Herings RMC: Effecten van chronisch/gecombineerd gebruik van geneesmiddelen [Effects of chronic and combined drug use]. Utrecht, The Netherlands, Vakgroep Praktische Farmacie,1989
52. Stolk RP, Grobbee DE: Epidemiologie van diabetes mellitus [Epidemiology of diabetes mellitus]. Diagnose Informatie en Medische Statistiek (DIMS) 12:4-7, 1992
53. Urquhart J: Role of patient compliance in clinical pharmacokinetics: a review of recent research. Clin Pharmacokinet 27:202-215, 1994
54. Buckalev LW, Sallis RE: Patient compliance and medication perception. J Clin Psychol 42:49-53, 1986
55. Lüscher TF, Vetter W: Adherence to medication. J Hum Hypertens 4 (Suppl. 1):43-46, 1990
56. Ary DV, Toobert D, Wilson W, Glasgow RE: Patient perspective on factors contributing to nonadherence to diabetes regimen. Diabetes Care 9:168-172, 1986
57. Cohen J: Power Analysis for the Social Sciences. New York, Academic, 1977
58. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR: The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 150:1881-1884, 1990
59. Haynes RB, Sackett DL, Taylor DW, Roberts RS, Johnson AL: Manipulation of the therapeutic regimen to improve compliance: conceptions and misconceptions. Clin Pharmacol Ther 22:125-130, 1977
60. Keen PJ: What is the best dosage schedule for patients? J R Soc Med 84:640-641, 1991
61. Levy G: A pharmacokinetic perspective on medication noncompliance. Clin Pharmacol Ther 54:242-244, 1993
62. Cramer JA, Mattson RH: Monitoring compliance with antiepileptic drug therapy. In Patient Compliance in Medical Practice and Clinical Trials. Cramer JA, Spilker B, Eds. New York, Raven Press, 1991, p. 123-137
63. Crome P, Akerhurst M, Keet J: Drug compliance in elderly hospital inpatients: trial of the Dosett box. Practitioner 30:329-333, 1980
64. Kjellgren KI, Ahlner J, Säljö R: Taking antihypertensive medication: controlling or cooperating with patients? Int J Cardiol 47:257-268, 1995
65. Murray MD, Birt JA, Manatunga AK, Darnell JC: Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packing. Ann Pharmacother 27:616-621, 1993
66. Mackowiak ED, O'Connor TW, Thomason M, Nighswander R, Smith M, Vogenberg A, Weissberger F, Wilkes W: Compliance devices preferred by elderly patients. Am Pharm NS34:47-52, 1994
67. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J: Compliance with topical pilocarpine treatment. Am J Ophthalmol 101:515-523, 1986
68. Norell SE: Monitoring compliance with pilocarpine therapy. Am J Ophthalmol 92: 727-731, 1981
69. Cramer JA, Ouellette VL, Mattson RH: Which medication dose is missed most frequently? (Abstract) Epilepsia 30:640, 1989